LLY - ELI LILLY & Co
869.58
-43.180 -4.966%
Share volume: 4,818,093
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$912.76
-43.18
-0.05%
View ratios
Fiscal Date | 09-30-2023 | 12-31-2023 | 12-31-2023 | 03-31-2024 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q3 2023 | Q4 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
Report Date | 11-02-2023 | 02-19-2025 | 02-21-2024 | 04-30-2024 | 04-30-2024 | 08-08-2024 | 10-30-2024 | 02-19-2025 | |
Cash flow financing | 572.000 M | 3.545 B | 3.545 B | -311.300 M | -311.300 M | 1.556 B | 211.300 M | -225.400 M | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | 2.190 B | 308.500 M | -311.900 M | -322.900 M | 1.166 B | 823.000 M | -81.500 M | 327.900 M | |
Net income | -57.400 M | 2.190 B | 2.190 B | 2.243 B | 2.243 B | 2.967 B | 970.300 M | 4.410 B | |
Depreciation | 411.000 M | 387.700 M | 387.700 M | 400.600 M | 400.600 M | 414.400 M | 466.800 M | 484.800 M | |
Changes in inventories | 4.901 B | 0.000 | 5.773 B | 0.000 | 6.102 B | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 10.364 B | 0.000 | 11.336 B | 0.000 | 10.014 B | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | -3.081 B | -2.924 B | -2.924 B | -1.178 B | -1.178 B | -2.199 B | -4.005 B | -1.921 B | |
Net Borrowings | 12.427 B | 0.000 | 16.607 B | 0.000 | 17.138 B | 0.000 | 0.000 | 0.000 | |
Investing Activity Other | 0.000 | -22.800 M | 0.000 | -65.200 M | 0.000 | 95.600 M | -169.800 M | -158.800 M | |
Dividends Paid | 0.000 | -1.018 B | 0.000 | -1.169 B | 0.000 | -1.172 B | -1.171 B | -1.168 B | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | -970.300 M | 1.071 B | -1.071 B | 986.300 M | -986.300 M | 1.225 B | 1.351 B | 1.496 B | |
Cash Change | 2.494 B | 437.800 M | 2.928 B | -358.400 M | 2.586 B | 763.400 M | 145.400 M | -100.600 M |